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In Brief
Chromosome 16p11.2 duplications
dramatically increase schizophrenia risk.
In this study, Bristow et al. show that the
mutation in mice suppresses GABAergic
neuron gene expression, disrupts activity
in hippocampal-orbitofrontal-
amygdaloid circuitry, and compromises
sociability and cognitive function. This
supports the concept that impairment of
this network is a core component of
schizophrenia.
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Chromosome 16p11.2 duplications dramatically in-
crease risk for schizophrenia, but the mechanisms
remain largely unknown. Here, we show that mice
with an equivalent genetic mutation (16p11.2
duplication mice) exhibit impaired hippocampal-or-
bitofrontal and hippocampal-amygdala functional
connectivity. Expression of schizophrenia-relevant
GABAergic cell markers (parvalbumin and calbindin)
is selectively decreased in orbitofrontal cortex, while
somatostatin expression is decreased in lateral
amygdala.When 16p11.2 duplicationmice are tested
in cognitive tasks dependent on hippocampal-orbi-
tofrontal connectivity, performance is impaired in
an 8-arm maze ‘‘N-back’’ working memory task
and in a touchscreen continuous performance task.
Consistent with hippocampal-amygdala dyscon-
nectivity, deficits in ethologically relevant social
behaviors are also observed. Overall, the cellular/
molecular, brain network, and behavioral alterations
markedly mirror those observed in schizophrenia
patients. Moreover, the data suggest that 16p11.2
duplications selectively impact hippocampal-amyg-
daloid-orbitofrontal circuitry, supporting emerging
ideas that dysfunction in this network is a core
element of schizophrenia and defining a neural cir-
cuit endophenotype for the disease.INTRODUCTION
Available drug treatments for schizophrenia (SZ) are effective
against the positive symptoms (hallucinations, delusions), at
least in the majority of patients, but are largely ineffective
against the negative (anhedonia, avolition, self-neglect, social
withdrawal) and cognitive (impaired working memory [WM]This is an open access article undand attention) symptoms. Development of improved treat-
ments will only be enabled by increased understanding of
the causes of the disease and how they impact on neurobi-
ology, and by better preclinical models of facets of the
disease.
The genetic architecture of SZ is complex (Giegling et al.,
2017). Many common sequence variations interact to increase
disease risk, although each common variant individually has
only a very small effect. It is therefore extremely challenging
to design rodent genetic models of the disease with high
construct validity, as any individual disease risk genetic variant,
of very small effect, is likely to have a relatively small disease-
relevant impact on CNS function. However, it is now clear that
in rare cases, single human copy-number variants (CNVs),
where small chromosomal sections are present in one or three
instead of two copies, can dramatically perturb CNS function on
their own and substantially increase disease risk. Of these
CNVs, the 22q11 (velocardiofacial/DiGeorge Syndrome) dele-
tion CNV has received considerable attention, as it substantially
increases risk of SZ (penetrance 6.5–18 [95% confidence inter-
val, CI]) (Kirov et al., 2014). A number of 22q11 mouse models
have consequently been developed to study the impact of
this CNV on CNS function, and, promisingly, impaired hippo-
campal-prefrontal synchrony has been reported (Sigurdsson
et al., 2010). Due to the relative difficulty of designing translat-
able behavioral assays for positive and negative symptoms of
the disorder, the resulting genetically modified (GM) mice are
commonly tested in cognitive tasks chosen to reflect the cogni-
tive deficits observed in patients with SZ. A difficulty is that
the 22q11 CNV is also associated with generalized cognitive
impairment and intellectual disability (ID) in almost all patients.
Hence, when mice modeling the 22q11 deletion are assessed
in cognitive tasks, any deficits observed are likely to reflect
aspects of general ID, rather than a specific SZ-related
impairment.
Other CNVs have been identified more recently that also
profoundly increase SZ risk. The 16p11.2 locus is attracting
special interest as, rather surprisingly, it is associated with
reciprocal risks for psychiatric and neurodevelopmentalCell Reports 31, 107536, April 21, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1. Alterations in Regional Centrality in 16p11.2 DUP Mice
Region Centrality Measure WT 16p11.2 Duplication
Hippocampus
Ventral hippocampus CA3 (VH-CA3) Eigenvector 2.08 1.02*
Ventral hippocampus DG (VH-DG) Eigenvector 2.05 2.65***
Basal Ganglia
Substantia nigra pars reticulata Eigenvector 2.04 2.66***
Substantia nigra pars compacta Betweenness 5.08 0.72*
Amygdala
Central amygdala eigenvector 2.04 1.36**
Mesolimbic
Nucleus accumbens core betweenness 5.34 0.13*
Septum
Lateral septum betweenness 6.73 0.52*
Sensory
Somatosensory cortex betweenness 8.08 0.42**
Auditory
Medial geniculate betweenness 4.47 0.59*
1Regions considered to be functional hubs in the brain networks (Z > 1.96).
Data shown as the Z score centrality measure within each group, calculated by comparison to 11,000 calibrated Erdo¨s-Re´nyi random networks. *p <
0.05, **p < 0.01, and ***p < 0.001 indicate significant difference from WT mice (55,000 permutations of the data).disorders. Carriers of a deletion at this locus have an increased
risk of autism-spectrum disorders (ASDs) and IDs, but not SZ
(Cooper et al., 2011; Stefansson et al., 2014, 2008; Weiss
et al., 2008). In fact the 16p11.2 deletion is among the most
common genetic variants in ASDs (Weiss et al., 2008). In
contrast, a high proportion of 16p11.2 duplication (16p11.2
DUP) carriers develop SZ (Kirov et al., 2014; Marshall et al.,
2017; McCarthy et al., 2009; Rees et al., 2014; Vassos et al.,
2010; Zheng et al., 2013), but only a small proportion also
have IDs (Cooper et al., 2011), and do not generally show
ASDs. The proportion of 16p11.2 DUP carriers developing
SZ appears to be similar to that of 22q11 deletion carriers
(penetrance 4.3–14) (Kirov et al., 2014; Marshall et al., 2017),
but since the 16p11.2 DUP increases risk of ID much less
than the 22q11 deletion, the phenotypic effects are more
specific to SZ (Kirov et al., 2014). In fact, the 16p11.2 DUP
represents one of the most powerful genetic risk factors
known for SZ (Marshall et al., 2017).
The genomic organization at this locus in themouse is compa-
rable to that in humans, allowing the generation of GM mice
with an equivalent (chr. 7F3) syntenic duplication (16p11.2
DUP mice) (Arbogast et al., 2016; Horev et al., 2011). The
16p11.2 DUP mice are without any overt behavioral phenotype,
but reportedly show subtle hypoactivity (Arbogast et al., 2016;
Horev et al., 2011). In this study, we utilize a range of translational
parameters that can be equated with clinical measures (Pratt et
al., 2012, 2018) to explore the neurobiological impact of theCNV,
and to assess the extent to which 16p11.2 DUP mice exhibit
functional abnormalities that resemble characteristics of pa-
tients with SZ. The findings have considerable significance for
future exploration of the neurobiological basis of the disease,
and for translational studies attempting to bridge the preclini-
cal-clinical barriers to drug development.2 Cell Reports 31, 107536, April 21, 2020RESULTS
Altered Functional Brain Network Connectivity in
16p11.2 Mice
Advances in imaging technologies and analytical methods,
including network science and related algorithms, have revealed
alterations in functional brain network connectivity in SZ. One of
the most consistent endophenotypes reported in SZ includes a
reduction in hippocampal-prefrontal cortex (PFC) connectivity
(Dawson et al., 2015b; Godsil et al., 2013; Sakurai et al., 2015).
There is some evidence that individual SZ risk genes/CNVs
(Dawson et al., 2015a; Sigurdsson et al., 2010) also impact
on functional brain network structure and hippocampal-PFC
connectivity in mice. We have therefore examined the properties
of functional brain networks of 16p11.2 DUP mice.
16p11.2 DUP mice exhibited selective alterations in constitu-
tive cerebral metabolism limited to the serotonergic raphe´, and
the striatum (Figure S2), showing significant hypometabolism
in the median raphe´ (MR) nucleus (p = 0.032, ANOVA), and hy-
permetabolism in the dorsolateral striatum (DLST, p = 0.003,
ANOVA) and ventromedial striatum (VMST, p = 0.015, ANOVA).
Hub Brain Region Status Is Altered in the Functional
Brain Networks of 16p11.2 DUP Mice
We found that regional functional connectivity was significantly
altered in 16p11.2 DUP mice, in terms of both regional impor-
tance (centrality) and inter-region functional connectivity (partial
least-squares regression (PLSR) analysis).
Regional importance in these functional brain networks was
characterized using centrality analysis (degree [Kc], between-
ness [Bc], Eigenvector [Ec]). Many of the brain regions identified
as important functional hubs in the brain networks of wild-type
(WT) animals were lost in 16p11.2 DUP mice. This included the
loss of hub regions in the ventral hippocampus (cornu ammonis 3
[VH-CA3] and dentate gyrus [VH-DG] subfields), the central
amygdala nucleus (CeA), and the substantia nigra (pars com-
pacta [SNc] and pars reticulata [SNr]). In addition, the nucleus
accumbens core (AcbC) and the lateral septum (LS) were identi-
fied as significant hubs in the functional brain networks of
WT mice that were significantly lost in those of 16p11.2 DUP
mice (Table 1). Two other brain regions, the medial geniculate
(MG; part of the auditory thalamus) and the primary somatosen-
sory (S1) cortex, also lost hub status in the functional brain net-
works of 16p11.2 DUP mice. This suggests that the organization
of functional brain networks is profoundly altered in 16p11.2
DUP mice. Full centrality data are shown in Table S2.
Despite these regional changes in functional connectivity,
when characterized at the global scale, we found that the prop-
erties of functional brain networks in 16p11.2 DUP mice were
not significantly altered in comparison to those in WT animals.
Functional networks in 16p11.2 DUP mice showed a similar
number of total functional connections (mean degree, < k >),
and had a similar average pathlength (Lp). There appeared to
be decreased clustering (Cp) in the brain networks of 16p11.2
DUP mice, but this did not reach statistical significance (p =
0.060, Figure S3).
PLSR Analysis Identifies Compromised Hippocampal,
Basal Ganglia, Amygdala, and Prefrontal Cortex
Functional Connectivity in 16p11.2 DUP Mice
Given the loss of functional hub brain regions in the brain net-
works of 16p11.2 DUPmice (Table 1), we sought to characterize
the alterations in inter-regional functional connectivity underlying
these losses. Therefore we employed the PLSR algorithm to
define the functional connectivity of these ‘‘seed’’ brain regions,
as previously described (Dawson et al., 2013, 2015a).
When the CA3 and DG subfields of the VH were used as seed
regions of interest (ROIs) in PLSR analysis, the evidence sup-
ported the significant loss of functional connectivity of these
hippocampal regions to multiple other hippocampal subfields
(DH-CA1, DH-CA2, DH-DG, VH-CA3, VH-DG, and VH-MoL),
the amygdala (CeA and medial amygdala [MeA]), and the PFC
(lateral orbital cortex [LO] subfield) in 16p11.2 DUP mice (abbre-
viations detailed in Table S1).)
When the CeA was considered as the seed ROI, we found
evidence for significantly lost connectivity to multiple hippocam-
pal subfields (DH-CA1, DH-CA2, VH-CA3, VH-DG, and entorhi-
nal cortex [ENT]), thalamic nuclei (anterior thalamic reticular nu-
cleus [aTRN]), mediodorsal thalamus [MD], and ventromedial
thalamus [VM]), and the SNR in 16p11.2 DUP mice. When the
AcbC was considered as the seed region, a significant decrease
in functional connectivity to the hippocampus (VH-DG, VH-MoL,
and ENT), basal ganglia (SNr and globus pallidus [GP]), and the
PFC (Cg1 and LO) was observed in 16p11.2 DUPmice (Figure 1).
When the substantia nigra (SNc and SNr) were considered
as seed brain ROI in the analysis, there was reduced connectivity
to the hippocampus (DH-CA1, DH-DG, VH-CA3, Ent, and perirhi-
nal cortex [PRh]), the CeA, nucleus accumbens (AcbS), and the
striatum (dorsolateral striatum - DLST and ventromedial striatum
- VMST) in 16p11.2 DUP mice. These effects were seen for the
SNR but not for the SNc, which showed altered connectivity tothe retrosplenial cortex (RSc), MG, and habenula (Hab) in
16p11.2 DUP mice (Figure 1).
In addition to these alterations, the differences in LS, MG, and
S1 cortex functional connectivity were also characterized in
16p11.2 DUPmice, again supporting compromised connectivity
of these regions to the PFC, amygdala, and hippocampal
subfields (Figure 1). Overall, these data support altered hippo-
campal, amygdala, basal ganglia, and prefrontal functional
connectivity as a result of 16p11.2 DUP. Full data are shown in
Table S2.
Any correlation between the regional functional activity of
individual mice and their behavioral phenotype would be of
significant interest. Therefore, we assessed the extent to which
locomotor activity (LMA) in an open field correlated with regional
cerebral metabolism inWT and 16p11.2 DUPmice (Figure S4). In
WT mice, cerebral metabolism in select subfields of the frontal
cortex (mPrL and dorsolateral orbital cortex [DLO]) and VH
(VH-CA1 and VH-MoL) was strongly related to LMA (Figure S4).
In addition, activity in the S1 and insular (Ins) cortices was
strongly related to LMA in WT mice, as was metabolism in the
GP and olfactory bulb (OB). Metabolism in many of the same
brain regions, including the DLO and Ins, was found to be
strongly related to LMA in 16p11.2 DUP mice. However, some
regions defined as being important to LMA in WT mice (e.g.,
VH-CA1, OB, and medial prelimbic cortex [mPrL]) were not
defined as being related to LMA in 16p11.2 mice (Figure S4).
By contrast, metabolism in multiple brain regions was strongly
and significantly related to LMA in 16p11.2 DUP but not WT
mice. This included metabolism in multiple cortical (LO and piri-
form cortex [Piri]), thalamic (anteromedial [AM] and reticular nu-
cleus [TRN]), and hippocampal (DH-MoL, dorsal subiculum
[DSub], and VH-DG) regions. In addition, cerebral metabolism
in the SNr, ventral limb of the diagonal band of Broca (VDB),
and CeA was strongly related to LMA in 16p11.2 DUP but not
WT mice. Intriguingly, many of the regions identified as showing
an altered contribution to LMA in 16p11.2 DUPmicewere hub re-
gions whose functional connectivity was significantly altered in
the brain networks of these animals (Figure 1; Table 1). This in-
cludes the CeA and DH-MoL, VH-DG, MG, S1, and SNR that
were identified as important functional hubs in the brains of
WT mice that significantly lost their hub connectivity status in
16p11.2 DUP mice. Overall, this suggests that dysfunction in re-
gions showing altered functional connectivity in 16p11.2 DUP
mice is related to their behavioral phenotype.
We noted some effects of sex on the network properties and
functional connectivity measures (Figure S5; Table S4). A num-
ber of brain regions were identified as being significant hubs
in the functional brain networks of female but not in male mice
(Table S2). This included the AM (eigenvector centrality) and
anteroventral (AV) (eigenvector centrality) thalamus, the RSc
(degree and eigenvector centrality), LS (betweenness centrality),
and the molecular layer of the ventral hippocampus (VH-ML,
betweenness centrality). In particular, there was evidence
for reduced hippocampal-orbitofrontal connectivity in males
compared to females (Figure S5). We also monitored brain
size, and found reductions throughout the neuraxis in the
16p11.2 DUP mice, consistent with previous reports (Horev
et al., 2011) (Figure S6).Cell Reports 31, 107536, April 21, 2020 3
Figure 1. Changes in Regional Functional Connectivity of 16p11.2 DUP Mice
(Top panel) Heatmap showing functional connectivity of ‘‘seed’’ regions. Seed regions were identified based on a loss of hub status in centrality analysis and a
significant difference in Z score in 16p11.2 DUPmice compared to the wild-type control group (Table 1). Light-blue panels indicate a significant (Z < -2.98) loss of
functional connectivity between the highlighted brain regions in 16p11.2 DUP mice compared to wild-type controls, as determined by PLSR analysis.
(Bottom panel) Coronal images of the mouse brain showing the localization of decreased regional connectivity for selected seed regions in 16p11.2 DUP mice.
Yellow denotes the location of the seed region; light blue denotes regions for which there has been a significant (Z <2.98) loss of connectivity to the seed region
in the 16p11.2 DUP mice as determined by PLSR analysis.
See Table S2 for full data of functional connectivity for all seed regions. See Table S1 for a full list of abbreviations. Mouse brain images aremodified from the Allen
Mouse Brain Atlas (http://mouse.brain-map.org/static/atlas). N = 6 males and 5 females per genotype.Altered GABAergic Interneuron Gene Expression in Lost
Functional Hubs in 16p11.2 DUP Mice
In light of the lost regional connectivity identified in 16p11.2
DUP mice, we next examined changes in GABAergic markers
in these regions. Reduced parvalbumin (Pvalb), calbindin, and
somatostatin (SST) expression in regions of the PFC and
orbitofrontal cortex (OFC) are arguably the most robust
neurochemical abnormality detected in post-mortem tissue
from patients with SZ (Hashimoto et al., 2008; Hoftman et al.,
2015). Thus, we characterized the regional expression of these
genes in 16p11.2 DUP mice. We found that the CNV was asso-
ciated with reduced expression of Pvalb and calbindin, in lateral
OFC. SST mRNA levels were decreased in the infralimbic (IL)
region of the PFC (Figure 2).GAD1 (encodingGAD67) expression
appeared unaffected in PFC and OFC regions, but was reduced
in the TRN, where Pvalb and calbindin expression were also
reduced (Figure 2). This is noteworthy, considering evolving the-
ories that TRN dysfunction is an early event in the development
of SZ (Pratt and Morris, 2015).
Having observed reduced hippocampal-amygdala connectivity
in 16p11.2 DUP mice, we also probed for GABAergic gene
expression deficits in the amygdala nuclei. Here, we detected4 Cell Reports 31, 107536, April 21, 2020decreased expression of calretininmRNA in themedial amygdala,
and decreased SST mRNA in the lateral amygdala (Figure 3).
Since the 16p11.2 DUP mice showed altered brain connectiv-
ity and gene expression changes across three primary
systems—orbitofrontal-hippocampal, hippocampal-amygdala,
and the basal ganglia—we then assessed performance
in behavioral tasks that recruit these systems, and which
are considered to have relevance to the positive, negative, and
cognitive symptom domains of SZ (Pratt et al., 2012, 2018).
16p11.2 DUP Mice Are Hypoactive and Exhibit Altered
Sensory Gating
We first examined if 16p11.2 DUP mice showed changes in a
range of fundamental physical parameters (SHIRPA battery)
that could influence performance in subsequent tests. No
significant effects of 16p11.2 DUP genotype were detected
(data not shown). We observed a (sex-dependent) reduction
in LMA in an open-field arena (novel environment) (Figure 4A),
with male 16p11.2 DUP mice showing a lower level of activity
compared to male WT control mice. This is consistent with pre-
vious reports showing that 16p11.2 DUP mice show reduced
levels of locomotion (Arbogast et al., 2016; Horev et al.,
Figure 2. 16p11.2 Duplication Decreases GABAergic Interneuron Gene Expression in Orbitofrontal Cortex and Thalamus
(A–D) Example autoradiographs are shown at the level of the prefrontal cortex (left), and hippocampus and thalamus (right), with box-and-whisker plots showing
group data.
(A) Parvalbumin (Pvalb).
(B) Calbindin (Calb1).
(C) Somatostatin (SST).
(D) Gad-67 (GAD1).
Boxplots show median with interquartile range and ‘‘Tukey’’ whiskers. Scale bar represents 2 mm. **p < 0.01 and *p < 0.05 (ANOVA) versus corresponding WT
group. Schematic diagrams (bottom left and right) show location of infralimbic (IL) cortex (orange), medial orbitofrontal (MO) cortex (red), lateral orbitofrontal (LO)
cortex (blue), hippocampal dentate gyrus (DG, purple), and thalamic reticular nucleus (TRN, green). N = 6 males and 6 females per genotype.2011). While 16p11.2 DUP mice showed no change in basic
startle amplitude in the prepulse inhibition (PPI) of the startle
response test (Figure S7), there was evidence for a reduction
in the PPI relative to WT mice (Figure 4D) (ANOVA p = 0.05)
that was more pronounced in female mice (Figure 4D) (ANOVA
p = 0.008).16p11.2 DUP Mice Exhibit Altered Social and Emotional
Behaviors
Impaired social functioning is a key feature of SZ, but there
are limitations in capturing the complexity and multidimensional
nature of this domain in rodent models (Millan and Bales, 2013).
In part this is because existing rodent paradigms involveCell Reports 31, 107536, April 21, 2020 5
Figure 3. 16p11.2 Duplication Decreases SST and Calretinin Expression in Amygdala
(A–D) Example autoradiographs are shown at the level of the amygdala, with box-and-whisker plots showing group data.
(A and B) Calb1.
(C) Calretinin (Calb2).
(D and E) GAD1.
(F) SST.
N = 6males and 6 females per genotype. Boxplots showmedian with interquartile range and Tukey whiskers. Scale bar represents 2mm. **p < 0.01 and *p < 0.05
(ANOVA) versus corresponding WT group.elements of stress responsivity, as behavior is monitored in a
novel environment often between unfamiliar animals and only
provides a snapshot of behavior over a limited time frame. We
therefore monitored behaviors in group housed mice in a
home-cage environment over a 3-day period. Mice showed
typical circadian patterns of activity (being more active in the
dark phase). Reduced LMA was again detected in 16p11.2
DUP mice, although this was more marked in female mice in
this case (Figures 4E and 4F).
16p11.2 DUP mice also showed signs of social impairment.
First, during the dark phase, average distance between cage-
mates was increased in 16p11.2DUP mice relative to WT con-
trols, and this genotype effect was more pronounced in males
(Figure 4G). Furthermore, over a 3-day period, 16p11.2 DUP
mice spent less time in close proximity (<50 mm) to cage-mates
(Figure 4H). Average time spent in close proximity to cage-mates
was reduced in 16p11.2 DUP mice, and this genotype effect was
most prominent during the light phase (Figure 4I). Since changes
in emotional behaviors may influence social functioning, we as-
sessed whether 16p11.2 DUP mice showed anxiety-like behav-
iors in the elevated plus maze. Male, but not female, 16p11.2
DUP mice showed signs of increased anxiety-like behavior,
spending less time in the open arms of an elevated plus maze
(Figure 4C). They also spent a smaller proportion of time than
their WT counterparts in the inner section of the open-field arena,
indicating an aversion to explore a novel environment (Figure 4B).6 Cell Reports 31, 107536, April 21, 2020We also looked to see if the pattern of behavior showed any
sign of changing over the 3-day period of monitoring. For both
locomotor and social measures, the phenotypes appeared
stable over the 3 days of testing (Figure S7).
16p11.2 DUP Mice Exhibit Deficits in Hippocampal-
Orbitofrontal Dependent Cognitive Tasks
Patients with SZ show a characteristic pattern of cognitive
impairment, notably in tasks that involve hippocampal-orbito-
frontal connectivity. We employed two behavioral tests designed
to interrogate aspects of cognitive function that have cross-spe-
cies commonalities in respect of neural circuitry, and hence
maximize rodent-human translational potential. The human
N-back task probes hippocampal-PFC-dependent short-term
WM processes, and deficits in this task are present in patients
with SZ (Meyer-Lindenberg et al., 2005; Schobel et al., 2009).
The eight-arm maze WM task (WMT) is an adaption of the radial
arm maze task that explores performance at increasing levels
of WM load (Marighetto et al., 2008) that has translational rele-
vance to the N-back WMT commonly used in patients. Thus,
here we will refer to the task as the rodent ‘‘N-back’’ WMT.
Separate cohorts of mice were assessed at two ages—
younger (10 weeks at start) and older (40 weeks at start).
This task requires considerable training, and, as expected,
there was a significant overall effect of training block (p <
0.001), with performance improving over the initial weeks,
Figure 4. Effect of 16p11.2 Duplication in Mice on Behavior
(A–D) Behavior in a novel environment and sensory motor gating.
(A) Locomotor activity.
(B) Time in inner zone of open-field arena, for male (left) and female (right) mice, in an open-field arena.
(C) Elevated plus maze, ratio of time in open arm compared to time in closed arm.
(D) PPI.
(E–I) Ethological behavior in home-cage environment over 3 days.
(E) Locomotor activity over 3 days. Continuous lines indicate group means, dotted lines indicate mean ± SEM; dark and light bars indicate dark and light phases.
Data shown for mixed sexes.
(F) Median distance traveled with interquartile range and Tukey whiskers.
(G) Median separation from cage-mates over 3 days, with interquartile range and Tukey whiskers.
(H) Proximity to cage-mates over 3 days, illustrated in the same way as (E).
(I) Median proximity with interquartile range and Tukey whiskers.
N = 6 males and 6 females (A–D) or 6 males and 9 females (E–H) per genotype. Data are shown either as mean ± SEM (B, E, and H), or as boxplots with median,
interquartile range, and Tukey whiskers. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05 (ANOVA), #p < 0.05, ##p < 0.01, and ####p < 0.0001 versus corre-
sponding WT group (post hoc Tukey test).but then stabilizing such that no significant additional improve-
ment was seen from training blocks 4 onward. As in the human
task, levels of performance decreased with increasing WM
load (increasing ‘‘n’’) (Figures 5A and 5B). There was an overall
significant effect of age, with older mice performing less well
than younger animals. There was a highly significant effect
of genotype, independent of the age of the mice, with
impaired performance in 16p11DUP mice (Figures 5A and
5B). Data from blocks 4–7, for both ages, were then pooled
for increased clarity, showing the impaired performance in
16p11.2 DUP mice (Figure 5C). There was no significant inter-action between 16p11.2 genotype and training block, indi-
cating that while 16p11.2 DUP mice showed a significant
deficit in WM performance, their ability to learn the task across
sessions was similar to that seen in WT mice. There was, how-
ever, a highly significant (p < 0.001) interaction between age
and training block, with the older mice learning less well
over time.
The reaction time for each choice is not measured in this task,
but total time to complete the task in each session was used as a
proxy measure of reaction time. While the time taken decreased
with training, 16p11DUP mice appeared slower than WTCell Reports 31, 107536, April 21, 2020 7
Figure 5. Effect of 16p11.2 Duplication in Mice on Performance in the N-back Task
(A and B) Task performance as% correct choices, across 5-day blocks of training sessions, in younger (A) or older (B) mice. Chance level of performance = 50%.
(C) Performance in training session blocks 4–7 with combined age groups.
(D) Time to complete task in younger mice, for blocks 4–7.
(E) Intra-individual variability (IIV) in younger mice for blocks 4–7.
N = 6 males and 6 females per genotype. Data are shown either as mean ± SEM, or as boxplots with median, interquartile range, and Tukey whiskers. Dots
represent outliers. ***p < 0.001 (ANOVA), #p < 0.05, ##p < 0.01, and ###p < 0.001 versus corresponding WT group, or as indicated (post hoc Tukey test).controls, reflecting much greater variability in completion time
(Figure 5D).
One of the most robustly-observed cognitive abnormalities
in patients with SZ is an increased intra-individual variability
(IIV) in processing speed (PS) in WM and attentional tasks,
including the N-back task (Cole et al., 2011; Manoach, 2003;
Zhou et al., 2014). When we monitored the IIV for the proxy
measure of total time to complete task, we observed a sex-spe-
cific effect, with female 16p11.2 DUP mice exhibiting greater IIV
than WT females or males (Figure 5E).
The rodent continuous performance task (CPT) has been
developed to mirror the widely-used human CPT, and employs
touchscreen apparatus to maximize cross-species equivalence
(Mar et al., 2013). Mice were trained according to Kim et al.
(2015). In this task, mice were assessed for attentional perfor-
mance (hit rate and false alarm rate), along with composite
measures of performance according to receiver operating char-8 Cell Reports 31, 107536, April 21, 2020acteristics, analogous to the measures commonly used in
clinical studies (perceptual sensitivity = d0 and index of response
bias = response indices [RIs]), and PS (reaction time). Patients
with SZ typically show reductions in d0, more liberal indices of
response bias, and reduced PS (Elveva˚g et al., 2000; Liu et al.,
1997). Patients with 16p11.2 DUPs exhibit reduced PS (Stefans-
son et al., 2014).
During acquisition of the task, (e.g., stage 3), 16p11.2 DUP
mice showed impaired performance, with lower hit rates and
d0 values, but also with reduced false alarm rates and RIs (Fig-
ures 6A–6D). Once the task was fully acquired, performance of
16p11.2 DUP mice was similar to WT mice, with d0 slightly
elevated, although RI values were substantially higher, indicative
of more liberal, risky responding (Figures 6E and 6F)
16p11.2 DUP mice also showed PS deficits, as evidenced
by slower reaction times (Figure 6G), although there was no indi-
cation of increased reaction time IIV in this task (Figure 6H).
DISCUSSION
The reason 16p11.2 duplications lead to dramatically enhanced
risk of SZ, without generalized ID, is of intense interest. We
demonstrate here that the CNV leads to a relatively selective
dysfunction of hippocampal-orbitofrontal-amygdaloid circuitry,
underpinned in part by GABAergic interneuron dysfunction,
along with corresponding behavioral effects, which, in addition
to reproducing aspects of the syndrome associated with
16p11.2 DUPs in humans, phenocopy many aspects of SZ itself.
We also found reduced brain size in 16p11.2 DUP mice, an
observation consistent with previous reports of 16p11.2 DUP
mice (Arbogast et al., 2016; Horev et al., 2011), and clinical re-
ports in 16p11.2 patients (Steinman et al., 2016). However,
despite the general reduction in brain size, the functional
alterations are neuroanatomically restricted. This includes the
loss of functional hub brain regions, paralleling the loss
of functional and structural hub regions in SZ (Rubinov and
Bullmore, 2013). We were intrigued to find that hippocampal-or-
bitofrontal networks were particularly affected by the CNV. There
is a major afferent pathway to the OFC from the hippocampus
(Barbas and Blatt, 1995; Godsil et al., 2013; Roberts et al.,
2007). Only relatively recently has it been widely appreciated
that orbitofrontal dysfunction is a core element of SZ (Godsil
et al., 2013; Homayoun and Moghaddam, 2008). Structural
changes in OFC are robustly observed in patients (Lacerda
et al., 2007; Nakamura et al., 2008; Sanfilipo et al., 2000), and
this pathway appears to become compromised at an early
stage, as changes are detected in parallel with the onset of psy-
chosis in at-risk populations, in parallel with cognitive impair-
ment (Guo et al., 2014; Pantelis et al., 2003; Salvador et al.,
2010). Patients with chronic SZ show clearly altered functional
activity in hippocampal and orbitofrontal regions (Schobel
et al., 2009), and actively hallucinating patients show elevated
metabolic activity specifically in hippocampus and OFC (Silbers-
weig et al., 1995). Hippocampal-orbitofrontal-amygdaloid cir-
cuitry is also specifically implicated in thought disorder—viewed
as a hallmark of SZ (Sumner et al., 2018). Our findings, that a
major consequence of 16p11.2 DUP is compromised hippocam-
pal-orbitofrontal connectivity, are consistent with the concept
that dysfunction of this pathway can be a fundamental cause
of SZ. Indeed, previous studies have reported OFC dysfunction
in other genetic (Dawson et al., 2014a; Johnson et al., 2013) and
pharmacological (Dawson et al., 2014b) rodent models relevant
to the disorder.
Amygdala-hippocampal connectivity is profoundly involved
with emotion, anxiety, and social engagement. A substantial
literature describes amygdala-hippocampal dysfunction in psy-
chiatric disease (discussed below).
GABAergic Molecular Alterations in 16p11.2 DUP Mice
Parallel Changes Seen in Patients with SZ
Patients with SZ show reduced expression of Pvalb and SST in
GABAergic interneurons in prefrontal and orbitofrontal cortices
(Beasley and Reynolds, 1997; Hoftman et al., 2015; Fung et al.,
2010; Hashimoto et al., 2008; Joshi et al., 2015; Morris et al.,
2008). It is therefore extremely pertinent that the 16p11.2 CNV
is sufficient to cause abnormal Pvalb and SST in prefrontal/orbi-tofrontal regions. Reduced calbindin expression is also reliably
detected in post-mortem PFC from patients with SZ (Beasley
et al., 2002). The observed decrease in calbindin mRNA in the
medial orbital cortex is therefore also important. The lack of
change in PFC/orbitofrontal calretinin expression is also broadly
consistent with results in patient tissue (Beasley et al., 2002;
Hoftman et al., 2015). It is notable that SST mRNA levels
are also reduced in the lateral amygdaloid nucleus in 16p11.2
DUP mice, paralleling the reduced SST mRNA levels reported
in the lateral amygdala in patients with SZ (Chang et al., 2017;
Pantazopoulos et al., 2017).
Overall, genes within the 16p11.2 region clearly control
SZ-relevant gene expression in prefrontal/OFC and amygdala.
Interestingly, reduced activity in SST neurones of the IL cortex
is sufficient to impair hippocampal-prefrontal synchrony (Abbas
et al., 2018), so the reduced SST expression seen in the IL in
16p11.2 DUP mice (Figure 2) may contribute to the lost hippo-
campal-PFC connectivity (Figure 1) seen in these animals.
However, it is also likely that the GABAergic interneuron alter-
ations localized to the LO cortex of 16p11.2 DUP mice also
play a key role in disrupting hippocampal-PFC connectivity in
these animals.
Alterations in Social- and Anxiety-like Behavior in
16p11.2 DUPMice Parallel those that are Seen in SZ and
Align with Their Functional Brain Connectivity Deficits
Impaired social cognition in SZ is an important determinant of
daily functioning and shows a strong relationship with positive
and negative symptoms (Green et al., 2015; Millan and Bales,
2013). This multidimensional construct includes the capacity to
detect, analyze, and interpret social signals from others,
together with recognizing and understanding their beliefs, inten-
tions, and actions (theory ofmind). This ultimately permits appro-
priate social behaviors. Clearly, there are challenges in capturing
elements of social cognition in rodents (Millan and Bales, 2013),
although measuring spontaneous social interactions in rodents
in a familiar home-cage environment offer considerable promise.
We show that 16p11.2 DUP mice express reduced social inter-
action behaviors in a low-stress, home-cage testing environ-
ment. A range of interconnecting neural networks are involved
in social cognition including the PFC, ventral striatum, amygdala,
and cingulate cortex (Barak and Feng, 2016; Bicks et al., 2015;
Grabenhorst et al., 2019). These neural systems all show
compromised functional connectivity in 16p11.2 DUP mice.
Furthermore, orbitofrontal-hippocampal connectivity has been
specifically linked to cognitive processes relating to social inter-
action (Ross et al., 2013). Thus our findings of reduced connec-
tivity among the OFC, amygdala, and hippocampus provide a
mechanistic substrate for the social deficits observed in the
16p11.2 DUP mice.
Social behaviors are influenced by emotional states, such as
anxiety. Notably, 16p11.2 DUP mice showed signs of increased
anxiety, albeit modest, in the elevated plus maze and open-field
test. This could potentially relate to a partially characterized
neural circuitry encompassing hippocampus, amygdala, OFC,
and raphe´ nuclei (Andrade et al., 2013; Shin and Liberzon,
2010). High anxiety is a feature of patients with 16p11.2 DUPs
(Filges et al., 2014; Knoll et al., 2018; Martin-Brevet et al.,Cell Reports 31, 107536, April 21, 2020 9
Figure 6. Effect of 16p11.2 Duplication in Mice on Performance in the Touchscreen rCPT
(A and B) HR (A) and FAR (B) at stage 3.
(A) HR Effect of genotype, p < 0.001.
(B) FAR Effect of genotype, p = 0.021.
(C and D) d0 (C) and RI (D) at stage 3.
(C) Stage 3 d0 effect of genotype, p < 0.001.
(D) Stage 3 response bias effect of genotype, p < 0.001.
(E and F) d0 (E) and RI (F) at stage 6.
(E) Stage 6 d0 effect of genotype, p < 0.01.
(F) Stage 6 response bias effect of genotype, p < 0.001.
(G and H) Reaction time incorrect responses (G) and reaction time IIV (H) at stage 6.
(legend continued on next page)
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2018; Rosenfeld et al., 2010), and also patients with SZ (Achim
et al., 2011).
The majority of the behavioral effects of the 16p11.2 DUP
were observed independently of the sex of the mice. A few
significant effects were sex dependent: while both males
and females demonstrated reduced LMA, for females this
was detected in the home-cage monitoring, while for males
this was detected in the novel environment of the open-field
arena. This suggests that phenotype manifestation in the
different sexes is potentially affected by additional factors,
notably the level of stress. The novel environment will involve
additional stress compared to the home cage, and indeed
male 16p11.2 DUP mice seem more sensitive than females
to anxiety-inducing situations, as exemplified by the results
in the elevated plus maze (Figure 4). In this context, it is inter-
esting that we found evidence for reduced hippocampal-orbi-
tofrontal connectivity in males compared to females (Fig-
ure S6), raising the possibility that males are therefore more
prone to the effect of the duplication to heighten anxiety. Sup-
porting the contribution of additional factors to the observed
sex-dependent phenotypes, both male and female 16p11.2
DUP mice showed reduced home-cage social interaction,
but for females this was apparent only for the separation-dis-
tance measure, whereas it was detectable for both sexes on
the proximity-time measure (Figure 4).
16p11.2 DUP Mice Show Deficits in Cognition Relevant
to Those Seen in Human Individuals with the 16p11.2
Duplication and Patients with SZ
SZ is typically associated with a specific profile of cognitive
dysfunction encompassing deficits in executive processes
including WM (e.g., N-back task), cognitive flexibility, and
attention (e.g., CPT). 16p11.2 DUP carriers (without co-morbid
SZ), show a relatively selective impairment in spatial WM
and reduced psychomotor PS, without affecting attention
or cognitive flexibility (as reflected by the degree of persev-
eration) (Stefansson et al., 2014)—suggesting that, without
effects related to the development of SZ, the cognitive
impairments are relatively limited in individuals with 16p11.2
DUPs.
The cognitive changes identified here in 16p11.2 DUP mice
strongly align with those reported in humans with 16p11.2
DUPs. For example, the performance of 16p11.2 DUP mice is
compromised in the N-back WM task, where they generate a
reduced number of correct responses compared to WT
mice. There is a spatial component to the mouse (maze-based)
N-back task, and hence the impairments in mice may be related
to the deficits in spatial WM seen in human 16p11.2 DUP
carriers.
Increased IIV is also a robust finding in SZ patients (Shin et al.,
2013), and has been linked to OFC function (Albaugh et al.,
2017). We noted evidence suggesting increased IIV in N-back
task performance in female 16p11.2 DUP mice. Indeed, in hu-(G) Reaction time for incorrect responding.
(H) IIV for incorrect responding reaction time.
N = 6 males and 6 females per genotype. Data are shown as mean ± SEM.
corresponding WT group (post hoc Tukey test).mans, IIV is greater in females than males in WM tasks (Dykiert
et al., 2012).
Interestingly, hippocampal-orbitofrontal dysconnectivity is
sufficient to cause these deficits. Orbitofrontal-hippocampal
functional connectivity is strengthened (Zald et al., 2014) during
performance of the N-back task in humans, and OFC lesions
compromise WM task performance in monkeys and humans
(Barbey et al., 2011; Iversen and Mishkin, 1970). Hence our
observation of GABAergic interneuron deficits in OFC and
impaired connectivity with hippocampus may explain the
impaired performance in the N-back task in 16p11.2 DUP
mice. These observations also parallel the reduced hippocam-
pal-PFC connectivity in another mouse model of a CNV relevant
to SZ—the 22q11.2 mouse model—linked to deficits in a WM
test equivalent to N-back n = 0 in the test used here (Sigurdsson
et al., 2010). Amygdaloid connectivity may also be important,
as a growing literature also implicates lateral OFC-amygdala
connections in value assessment of rewarding experience
(Chau et al., 2015; Malvaez et al., 2019).
Consistent with relatively spared attentional performance in
human 16p11.2 DUP carriers, 16p11.2 DUP mice performed
comparatively well in the CPT, despite some impaired perfor-
mance during task acquisition, and more risky responding
once the task was established. Interestingly, mice with a ge-
netic manipulation mirroring the 22q11 deletion CNV show
similar impairment at stage 3 of the CPT, with reduced hit
rate and increased false alarms (Nilsson et al., 2016)—
although, consistent with the more generalized ID associated
with this CNV in humans, they also show impaired hit rate at
stage 6.
Patients with SZ are impaired in the CPT, showing reduced
hit rates and d0, along with elevated false alarm rates, gener-
ally more impulsive responding, and slower reaction times
(Fleck et al., 2001). These characteristics were strikingly repro-
duced in the touchscreen CPT in 16p11.2 DUP mice. In the
CPT, the 16p11.2 DUP mice are slower to learn the task.
Although ultimately they achieve relatively normal levels of
performance in terms of hit rate, they continue to show more
risky responding strategies. Note that while higher RI values
are indicative of more liberal responding (Kim et al., 2015),
this is the converse of the complementary LnBeta index
used clinically, where low values indicate more liberal re-
sponding strategies.
The altered GABAergic interneuron gene expression and
functional connectivity we have detected in 16p11.2 DUP mice
may be directly responsible for the cognitive impairment. In
general, the role of the OFC, and especially lateral OFC, is
most commonly defined in terms of restraint and response
inhibition (Dias et al., 1996; Elliott et al., 2000), with OFC dysfunc-
tion typically leading to increased false alarm rates. OFC activity
increases during response inhibition, a phenomenon increased
in SZ (Schirmbeck et al., 2015). In fact, a highly-selective
impairment of OFC Pvalb cells is sufficient to cause such*p<0.05, **p<0.01,***p < 0.001 (ANOVA), #p < 0.05, and ##p < 0.01 versus
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cognitive deficits (Goodwill et al., 2018) (increased false-re-
sponding during cognitive challenge).
The Role of Individual 16p11.2 Genes in SZ-Relevant
Phenotypes
Although there are ~30 genes within the human CNV, some
insight is available into the contribution of specific genes to the
phenotypes observed. It should be noted that the mouse strain
used here has a duplication of these and also three additional
genes (Cd2bp2, Tbc1d10b, and Sept1). Although these three
genes are not part of the core duplication in humans, they report-
edly also show elevated expression in tissues from human
16p11.2 DUP carriers (Blumenthal et al., 2014). While they do
represent a slight variation from the humanmutation, where there
is commonality between the assays that we have used and those
used by Arbogast et al. (2016) (brain size, LMA) in which the
mouse duplication more exactly matches the human core dupli-
cation, we note that there is good correspondence between the
two strains of mice. In terms of 16p11.2 genes and neurobiolog-
ical sequelae, the microencephaly phenotype is reproduced in
zebrafish as a result of KCTD13 overexpression (but not of other
16p11.2 genes) (Golzio et al., 2012). ERK1 is important for many
aspects of cognitive function, so Mapk3 duplication may
contribute to the cognitive phenotypes we report. Increased
LMA in Mapk3 knockout mice (Mazzucchelli and Brambilla,
2000; Selcher et al., 2001) implicates duplication of this gene in
the hypolocomotor phenotype. However, Mapk3 knockout mice
show normal PPI and anxiety behavior (Selcher et al., 2001). It
has recently become clear that c-jun N-terminal kinase (JNK)
signaling makes a substantial contribution to the regulation of
anxiety (Mohammad et al., 2018; Stefanoska et al., 2018), with
a lack of JNK being anxiolytic. Mice with a genetic deletion spe-
cifically of the Taok2 gene exhibit reduced anxious behavior in a
novel environment (Richter et al., 2019), linking Taok2 to anxiety
mechanisms. Since TAOK2 is an upstream activator of JNK,
the hyper-anxiety in (male) 16p11.2 DUP mice can potentially
be ascribed to the duplication of the Taok2 gene within the
CNV. Mice lacking Taok2 also show hyperlocomotion (Richter
et al., 2019), so the hypoactive phenotype of 16p11.2 DUP
mice may also result from increased Taok2 gene dosage. Much
future work is needed to dissect the specific relationships that
exist between single genes in the 16p11.2 region, or potential
synergistic interactions between these genes, and the generation
of translationally relevant phenotypes.
Synthesis of Findings
The overall picture that emerges from these studies is that the
16p11.2 DUP impacts on hippocampal-orbitofrontal and hippo-
campal-amygdala pathways. The results are consistent with
data emerging from other murine genetic models of rare, high-
penetrance SZ risk, and also with some recent evidence from
16p11.2 deletion mice. It will be important to build on this knowl-
edge, to understand the role of specific genes within the CNV
in the rather anatomically specific disruption of function. The
SZ-relevant behavioral deficits that we have detected are all
consistent with reduced prefrontal/orbitofrontal expression of
SST and Pvalb, and compromised hippocampal-orbitofrontal
communication. Interestingly, OFC Pvalb cells are particularly12 Cell Reports 31, 107536, April 21, 2020sensitive to early-life stress (Goodwill et al., 2018), so the
poorly-characterized interactions with environmental risk may
also converge on this pathway. Here we show deficits in hippo-
campal-orbitofrontal-amygdalar circuity that are accompanied
by deficits in cognitive subdomains and social deficits in
highly translatable tasks. Importantly, this ‘‘circuitry-cellular
and behavioral’’ phenotype closely aligns with deficits observed
in patients with duplications in 16p11.2. Thus, the data provide
insight into how the CNV affects cognition, and increases the
risk of developing SZ, in humans. Furthermore, the data support
the use of 16p11.2 DUP mice as a model of high construct
validity, with translational phenotypes, which can be utilized
for future drug development studies.
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Materials Availability Statement: There are no newly generated materials or tools associated with this report, and this study did not
generate new unique reagents. The GM mouse strain is available from Jackson Laboratories.
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the Lead Contact: Brian J.
Morris (brian.morris@glasgow.ac.uk)
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Mice hemizygous for the 0.44-Mb region of mouse chromosome 7, syntenic to the human 16p11.2 duplication, were generated by
Mills and colleagues (Horev et al., 2011) (Jackson Laboratory stock No. 016915), and backcrossed onto a C57BL/6 background to
generate the experimental mice used in these studies (16p11.2 DUPmice). 16p11.2 DUPmice, and littermate wild-type (WT) controls,
were housed on site for a minimum of 2 weeks prior to experimental use, group housed under standard conditions, with food ande1 Cell Reports 31, 107536, April 21, 2020
water ad libitum, under reversed light/dark cycle (lights off at 10am). Mice were used at 63-79 days old for functional imaging, at
49-63 days old for simple behaviors and in situ hybridization, and as detailed for cognitive behaviors, and were tested in randomized
order. All work was approved by the relevant University Animal Welfare and Ethics Review Board (AWERB) and conducted in
accordance with the UK Animals (Scientific Procedures) Act 1986.
METHOD DETAILS
In Situ Hybridization
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous
experiments with GMmice, to provide 99%power to detect an effect at p < 0.05 (Minitab). Regional mRNA expressionwasmonitored
by in situ hybridization according to our published methods (Wisden and Morris, 1994) using 35S-labeled 45-mer oligonucleotide
probes complementary to target mRNAs. 20 mm frozen cryostat sections were mounted on microscope slides coated with
poly-L-Lysine (Sigma) and fixed for 10 minutes in 4% paraformaldehyde (Sigma) on ice. Oligonucleotides were 30end-labeled with
35S-dATP using terminal deoxynucleotidyl transferase (ThermoFisher). Hybridization with sections was performed at 42C overnight
in a humidified chamber, and the next day sections were washed for 1 hour in standard saline citrate buffer (Sigma) at 55C, before
being dehydrated in ethanol. Specificity of labeling was assessed using competition controls (25x excess of unlabeled oligonucle-
otide) (Johnston and Morris, 1994; Wisden et al., 1990; Wisden and Morris, 1994). Autoradiographic signal intensity was measured
using ImageJ (Schneider et al., 2012), while blind to the genotype and sex of the samples.
14C-2-Deoxyglucose Imaging
Group size: WT, n = 10 (6 male, 5 female) and 16p11.2 DUP, n = 10 (6 male, 5 female) was estimated, based on our previous
experiments with GM mice, to provide 85% power to detect an effect at p < 0.05 (Minitab). 14C-2-deoxyglucose (14C-2-DG)
functional brain imaging was conducted in accordance with previously published protocols (Dawson et al., 2013, 2012). Autoradio-
graphic signal intensity was measured using a MCID system, while blind to the sex and genotype of the samples.
Network Analysis using Graph Theory Algorithms
Using network science/graph theory algorithms, global functional brain network structure properties and regional centrality analysis
were analyzed using the igraph package (Csa´rdi and Nepusz, 2006) in R (R Core Team, 2018). The application of brain network
analysis to 14C-2-DG brain imaging data has previously been described in detail (Dawson et al., 2015b, 2013, 2012). The algorithms
applied here allow us to define the properties of functional brain networks at the global scale (mean degree (< k > ), average path
length (Lp) and clustering coefficient (Cp)) and to also define the importance of each brain region in the context of the whole brain
network (centrality analysis; degree (ki), betweenness (Bc) and Eigenvector (Ec)).
Partial Least-Squares Regression (PLSR)
The application of PLSR to functional 14C-2DG brain imaging data and it interpretation has been considered elsewhere in detail
(Dawson et al., 2013, 2012). Data were analyzed using the Pls package (Mevik et al., 2019) in R. Significant inter-regional connectivity
to the ‘‘seed’’ RoI being analyzed was considered to exist within the experimental group if the lower bound of the 95% confidence
interval (CI) of the variable importance to the projection (VIP) statistic (estimated by jack-knifing) exceeded the 1.0 threshold.
Significantly altered connectivity in 16p11.2 DUP mice was determined by statistical comparison of the VIP statistic between
experimental groups through the calculation of the standardized z-score, with a z-score <2.98 considered to be significant. Signif-
icantly lost connectivity was confirmed by a 95% CI of the VIP > 1.0 in WT mice that was not present in 16p11.2 DUP mice (95% CI
lower bound VIP < 1.0).
Using PLSR Analysis to Define Altered Relationships between Regional Cerebral Metabolism and Locomotor Activity
(LMA) in 16p11.2 DUP Mice
To define the relationship between regional cerebral metabolism and LMA in experimental animals we employed the partial least-
squares regression (PLSR) algorithm, which allows the quantification of the contribution of multiple, collinear explanatory ‘‘predictor’’
variables (X variables, in this case regional local cerebral glucose utilization) to one dependent variable (Y variable, in this case the
relevant LMAmeasure). For a detailed overview of PLSR see Dawson et al. (2012); Wold (1995), andWold et al. (2001). In this way the
PLSR algorithm can model the relationship between regional cerebral metabolism and behavioral outcome measures.
Our data were analyzed using the PLSR package (Mevik et al., 2019) in R (R Core Team, 2018). The variable importance to the
projection (VIP) statistic provides a summary of the relationship between the X and Y variables, with VIP values > 1 defined asmaking
a large contribution to determining the values in X and Y (Wold et al., 2001). On this basis we calculated the VIP statistic for each
brain region of interest (RoI) in relation to the four measures of LMA of interest (distance, velocity, movement frequency and move-
ment duration) in the two experimental groups (WT and 16p11.2 DUP mice). Through a jack-knifing (‘‘leave-one-out’’) procedure the
standard deviation (SD) of the VIP statistic was estimated for each explanatory brain RoI andwithin each experimental group, and the
lower bound of the 95% confidence interval (CI) for the VIP statistic determined. Within each experimental group the average 95%CI
lower bound of the VIP statistic across the four locomotor measures was determined, with an average value > 1 considered toCell Reports 31, 107536, April 21, 2020 e2
indicate a substantial relationship between RoI metabolism and locomotor activity. Group differences in locomotor activity
were determined through calculation of the average standardized z-score from each model (per LMA variable and genotype), with
z > 1.96 or < 1.96 considered to be significant.
Gross Morphology
Brain size was determined by measuring the area of the brain autoradiograms gained in the 14C-2-deoxyglucose brain imaging
study at 7 levels across the brain (Figure S6). We also analyzed the coronal sectional area of selected brain regions including the
striatum, anterior thalamus (athal), medial thalamus (mthal) and the substantia nigra. In addition, we measured the cortical depth
of several cortical regions, including the auditory cortex.
Open Field Arena
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous
experiments with GM mice, to provide 88% power to detect an effect at p < 0.05 (Minitab). Locomotor activity was assessed in
an arena, made of black Perspex (size 40 3 40 3 40cm), semi-permeable to infrared light, lit from below by infrared LEDs. Activity
was monitored and recorded using an infrared-sensitive digital camera (Sony) and EthoVision XT software (Noldus Information
Technology). Each mouse was placed initially in the center of each arena. All animals were tested for 60 minutes, with no prior habit-
uation period
Elevated Plus Maze
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous
experiments with GM mice, to provide 80% power to detect an effect at p < 0.05 (Minitab). Plus maze apparatus consisted of two
opposing enclosed, dark arms (30 cm x 6 cm) and two opposing open light arms (30 cm x 6 cm). The mouse was placed in center
of the maze and allowed to freely move for 5 minutes. An overhead infra-red detecting camera tracked and analyzed activity. Data
were analyzed using EthoVision Video Tracking System (Noldus Information Technology, Leesburg, VA).
PPI
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous
experiments with GM mice, to provide 92% power to detect an effect at p < 0.05 (Minitab). Using SR-LAB chambers (San Diego
Instruments, San Diego, CA) as previously described (Openshaw et al., 2020), a startle curve (random presentation of 60 trials of
65dB, 69dB, 73dB, 77dB, 85dB, 90dB, 100dB, 110dB, 120dB - full spectrum white noise) was obtained. Pre-pulse inhibition deter-
mination involved randompresentation of 120dB startle with 4, 8 and 16 db above a background dB level of 65dB (full spectrumwhite
noise). % PPI was calculated as startle reactivity at 120 dB – startle reactivity with prepulse) / startle reactivity at 120 dB x 100).
N Back Radial Maze Task
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous exper-
iments with GM mice, to provide 80% power to detect an effect at p < 0.05 (Minitab). The N-back test was performed as described
in Marighetto et al. (2008) using 6 arms from an automated 8 arm radial mazes (Med Associates Inc., St Albans, Vermont), with an
automated pellet dispenser delivering a single reward pellet (Test Diet, formula 5TUL 14mg), at the end of each arm. The configuration
and procedure is shown schematically in Figure S1. The 6 arms used were counterbalanced across groups to avoid any confounds
due to inherent bias in the mazes. Following habituation (3 days of free access to the maze where all arms were accessible and 2
pellets placed in the food hoppers at the end of each arm), the full test schedule of 23 trials began, incorporating equal numbers
of trials for each value of N. The 6 arms were allocated to 1 of 3 pairs of arms (pair A, B and C) which were presented in a random
order. Following an initial presentation of a given pair (free choice; rewarded) a reward was delivered only when the alternative
arm was selected from that selected in the previous presentation of the arm pair. The N-back set was then constructed from the in-
dividual trial set by the number of intervening alternative arm pair presentations (Marighetto et al., 2008).
CPT
Group size: WT, n = 12 (6 male, 6 female) and 16p11.2 DUP, n = 12 (6 male, 6 female) was estimated, based on our previous exper-
iments with GM mice, to provide 86% power to detect an effect at p < 0.05 (Minitab). The CPT was performed using Campden in-
struments mouse touchscreen operant boxes, running the ABETII touch software package. A 3 aperture horizontal mask allowed
selection of 3 discrete sections of the touchscreen. The center panel presented the task stimulus. For correct responses, (YazooTM)
strawberry milkshake, delivered at 70 ml, represented the reward, a tone played and the food reward hopper illuminated. Stimuli were
either S+, which was rewarded following a response, or S-, which were punished following a response by a correction phase with
repeated stimulus presentation until the response is correctly withheld. The configuration and procedure is shown schematically
in Figure S1. Training was performed as described (Kim et al., 2015) with basal response learning (stage 1), stimulus-specific re-
sponding (stage 2), stimulus-specific responding and non-responding (stage 3), followed by increased cognitive load (e.g., increased
S- stimuli; reduced stimulus presentation times (2 s, 1.5 s, 1 s; limited hold 2.5 s, 2 s, 1.5 s) in stages 4-6). Parameters were: Hit rate
(HR) - the rate at which animals respond to correct S+ stimulus (HR =Hit/(Hit+Miss)); False alarm rate (FAR) - the rate at which animalse3 Cell Reports 31, 107536, April 21, 2020
respond to the S- stimulus and is a composite score composed as follows: FAR = False alarm/(False alarm + Correct rejection);
Sensitivity index (SI) - the perceptual discriminability between the S+ and S; i.e., higher values indicate better visual discrimination
(Kim et al., 2015); Responsivity index (RI) - the criterion or willingness to make responses, e.g., conservative = low RI values while
liberal = high RI values (Kim et al., 2015; see erratum for correct formula). Note that this is the converse of the LnBeta index, where
low values indicate more liberal responding strategies.
Home Cage Monitoring
Group size: WT, n = 15 (6 male, 9 female) and 16p11.2 DUP, n = 15 (6 male, 9 female) was estimated, based on our previous
experiments with GM mice, to provide 93% power to detect an effect at p < 0.05 (Minitab). A radiofrequency identification (RFID)
transponder (Biomark, UK) was implanted subcutaneously into the lower left abdominal quadrant under isofluorane anesthesia a
minimum of 2 days before recording. Groups of 3 mice were then placed in Plexiglas IVC cages monitored by the Home Cage
Analyzer (Actual Analytics Ltd, UK) (Bains et al., 2016, 2018) equipment for 1.5h prior to data acquisition in order to habituate the
animals. Recording commenced at 10am and proceeded for 72h. Measures included: total distance traveled (mm), total number
of antenna transitions, separation (mean Euclidean distance to closest cage-mate (mm)) and proximity (time spent < 75mm apart
from cage-mates (s)).
QUANTIFICATION AND STATISTICAL ANALYSIS
The statistical details of experiments can be found in the figure legends and in Table S7. All data were tested for normality of
distribution prior to the use of ANOVA (Minitab).
DATA AND CODE AVAILABILITY
This study did not generate searchable datasets or code.Cell Reports 31, 107536, April 21, 2020 e4
